Turner Investments’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-7,330
Closed -$203K 102
2017
Q2
$203K Sell
7,330
-1,380
-16% -$36.6K 0.13% 185
2017
Q1
$217K Sell
8,710
-116,210
-93% -$2.83M 0.14% 179
2016
Q4
$2.7M Sell
124,920
-97,320
-44% -$2.12M 1.09% 13
2016
Q3
$5.29M Buy
222,240
+20,900
+10% +$499K 1.75% 8
2016
Q2
$4.71M Sell
201,340
-10,260
-5% -$222K 1.47% 14
2016
Q1
$3.98M Buy
211,600
+108,700
+106% +$1.91M 1.08% 27
2015
Q4
$1.9M Buy
102,900
+36,500
+55% +$654K 0.39% 80
2015
Q3
$1.09M Buy
+66,400
New +$1.13M 0.22% 134

Other funds holding BSX

Turner Investments's BSX Position: Q3 2017 in Review

Turner Investments sold out of Boston Scientific (BSX) in Q3 2017, closing a stake of 7,330 shares — an estimated $203K sold.

Turner Investments first reported a position in BSX in Q3 2015 and held it in 8 quarters. The position peaked at $5.29M in Q3 2016. 547 funds tracked by Wall St. Rank hold BSX as of Q3 2017.

  • Turner Investments reported no remaining Boston Scientific position as of Q3 2017 after selling out during the quarter.
  • Turner Investments sold 7,330 Boston Scientific shares in Q3 2017, an estimated $203K.
  • Turner Investments first reported a position in Boston Scientific in Q3 2015 and held it in 8 quarters.
  • Turner Investments's Boston Scientific position peaked at $5.29M in Q3 2016.
  • 547 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2017.

Based on Turner Investments's 13F filing for Q3 2017, filed 8 Nov 2017.